Officials from the Drugs Control Administration carried out raids on multiple pharmaceutical dealers in Koti, Hyderabad. | Photo Credit: Special Arrangement Officials from the Drugs Control Administration (DCA) carried out raids on multiple pharmaceutical …

… -stage clinical trials. Merck’s Cholesterol Medication Achieves Primary Endpoint in Two …

Fresh findings from a large clinical trial are helping build the case that an experimental drug for cardiovascular illness could also be useful in combating Alzheimer’s disease. The drug, known as obicetrapib, is designed to block a protein that regulates …

… and efficacy of its oral cholesterol drug, sending shares of the company …

AI-generated image. The patients came in with high cholesterol. And it was the kind that clings stubbornly to arteries and shadows families for generations. They walked into a clinical trial and left, perhaps, with a glimpse of the future. In early results …

NewAms­ter­dam Phar­ma’s stock ticked up­ward on Mon­day af­ter a bio­mark­er analy­sis of its ex­per­i­men­tal cho­les­terol-low­er­ing drug showed promise in Alzheimer’s dis­ease. The drug, a CETP …

anusorn nakdee/iStock via Getty Images Merck (NYSE:MRK) said on Monday that the company's late-stage trials evaluating its oral cholesterol pill, enlicitide decanoate, met main goals. The two trials showed that its potential blockbuster, enlicitide …

(Reuters) -Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies. The drug, enlicitide decanoate, is being evaluated as a treatment for hyperlipidemia, a condition where there is elevated buildup of fat …

Rachel Cronin Trainee Trends Writer and Eleanor Tolbert Reporter 08:13 ET, 05 Jun 2025 In a groundbreaking development, an AI-powered 'scientist' has made a significant discovery in the field of cancer treatment. The AI model GPT-4, working in …